Skip to content

Released May 7, 2015, after the close

10-Q filed May 7, 2015, 37 days after period end · 0001390478-15-000024

Q1 2015 · 10-Q
Revenue$2.75M+26.6% vs Q1 2014−13.9% vs Q4 2014
Net Income-$10.54MN/M vs Q1 2014N/M vs Q4 2014
EPS Diluted-$0.08N/M vs Q1 2014no prior Q4 2014 on file
Operating Income-$8,912,000N/M
Operating Cash Flow-$11,556,000N/M
Free Cash Flowderived-$11,574,000N/M
Margins · derived
Operating margin-324.1%+221.2 pt vs Q1 2014
Net margin-383.2%−266.5 pt vs Q1 2014

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2015Q1 2014Q1 2013Q1 2012
Revenue$2.75M$2.17M$2.75M$2.75M
Net Income-$10.54M-$2.54M-$16.49M-$10.54M
EPS Diluted-$0.08-$0.02-$0.11-$0.52

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR